Skip to main content

Abstract

The risk of suffering a bone fracture increases following kidney transplantation. This elevated risk continues for the life of the transplant,1 only increasing with time.2 By 5 years post-transplant up to 50% of patients experience at least one fracture. Reported fracture incidences in transplant recipients range anywhere from 5% to greater than 60%.1,2 This wide range of reported fracture rates is a consequence of the varied methodology used in obtaining these data. Whether determining fracture rates by questionnaire or patient encounter notes or looking for radiographic evidence dramatically affects the result.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Vautour LM, Melton LJ 3rd, Clarke BL, Achenbach SJ, Oberg AL, McCarthy JT. Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int 2004 Feb;15(2):160–167.

    Article  PubMed  Google Scholar 

  2. Sprague SM, Josephson MA. Bone disease after kidney transplantation. Semin Nephrol 2004 Jan;24(1):82–90.

    Article  PubMed  Google Scholar 

  3. Ramsey-Goldman R, Dunn JE, Dunlop DD, Stuart FP, Abecassis MM, Kaufman DB et al. Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res 1999 Mar;14(3):456–463.

    Article  CAS  PubMed  Google Scholar 

  4. Stehman-Breen CO, Sherrard DJ, Alem AM, Gillen DL, Heckbert SR, Wong CS et al. Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int 2000 Nov;58(5):2200–2205.

    Article  CAS  PubMed  Google Scholar 

  5. Ball AM, Gillen DL, Sherrard D, Weiss NS, Emerson SS, Seliger SL et al. Risk of hip fracture among dialysis and renal transplant recipients. JAMA 2002 Dec 18;288(23):3014–3018.

    Article  PubMed  Google Scholar 

  6. Braithwaite RS, Col NF, Wong JB. Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc 2003 Mar;51(3):364–370.

    Article  PubMed  Google Scholar 

  7. Abbott KC, Oglesby RJ, Hypolite IO, Kirk AD, Ko CW, Welch PG et al. Hospitalizations for fractures after renal transplantation in the United States. Annals of Epidemiol 2001 Oct;11(7):450–457.

    Article  CAS  Google Scholar 

  8. Borah B, Gross GJ, Dufresne TE, Smith TS, Cockman MD, Chmielewski PA et al. Three-dimensional microimaging (MRmicroI and microCT), finite element modeling, and rapid prototyping provide unique insights into bone architecture in osteoporosis. Anat Rec 2001 Apr;265(2):101–110.

    Article  CAS  PubMed  Google Scholar 

  9. Marcen R, Caballero C, Uriol O, Fernandez A, Villafruela JJ, Pascual J et al. Prevalence of osteoporosis, osteopenia, and vertebral fractures in long-term renal transplant recipients. Transplant Proc 2007 Sep;39(7):2256–2258.

    Article  CAS  PubMed  Google Scholar 

  10. Parker CR, Freemont AJ, Blackwell PJ, Grainge MJ, Hosking DJ. Cross-sectional analysis of renal transplantation osteoporosis. J Bone Miner Res 1999 Nov;14(11):1943–1951.

    Article  CAS  PubMed  Google Scholar 

  11. Durieux S, Mercadal L, Orcel P, Dao H, Rioux C, Bernard M et al. Bone mineral density and fracture prevalence in long-term kidney graft recipients. Transplantation 2002 Aug 27;74(4):496–500.

    Article  CAS  PubMed  Google Scholar 

  12. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ (Clinical research ed.) 1996 May 18;312(7041):1254–1259.

    CAS  PubMed  Google Scholar 

  13. Monier-Faugere MC, Mawad H, Qi Q, Friedler RM, Malluche HH. High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol 2000 Jun;11(6):1093–1099.

    CAS  PubMed  Google Scholar 

  14. Cockerill W, Lunt M, Silman AJ, Cooper C, Lips P, Bhalla AK et al. Health-related quality of life and radiographic vertebral fracture. Osteoporos Int 2004 Feb;15(2):113–119.

    Article  CAS  PubMed  Google Scholar 

  15. Dooley AC, Weiss NS, Kestenbaum B. Increased risk of hip fracture among men with CKD. Am J Kidney Dis 2008 Jan;51(1):38–44.

    Article  CAS  PubMed  Google Scholar 

  16. Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006 Jun;69(11):1945–1953.

    Article  CAS  PubMed  Google Scholar 

  17. Cruz DN, Wysolmerski JJ, Brickel HM, Gundberg CG, Simpson CA, Mitnick MA et al. Parameters of high bone-turnover predict bone loss in renal transplant patients: a longitudinal study. Transplantation 2001 Jul 15;72(1):83–88.

    Article  CAS  PubMed  Google Scholar 

  18. Sprague SM, Belozeroff V, Danese MD, Martin LP, Olgaard K. Abnormal bone and mineral metabolism in kidney transplant patients – a review. Am J Nephrol 2008;28(2):246–253.

    Article  CAS  PubMed  Google Scholar 

  19. Messa P, Sindici C, Cannella G, Miotti V, Risaliti A, Gropuzzo M et al. Persistent secondary hyperparathyroidism after renal transplantation. Kidney Int 1998 Nov;54(5):1704–1713.

    Article  CAS  PubMed  Google Scholar 

  20. Edwards RM, Contino LC, Gellai M, Brooks DP. Parathyroid hormone-1 receptor down-regulation in kidneys from rats with chronic renal failure. Pharmacology 2001 May;62(4):243–247.

    Article  CAS  PubMed  Google Scholar 

  21. Parfitt AM. The hyperparathyroidism of chronic renal failure: a disorder of growth. Kidney Int 1997 Jul;52(1):3–9.

    Article  CAS  PubMed  Google Scholar 

  22. Bonarek H, Merville P, Bonarek M, Moreau K, Morel D, Aparicio M et al. Reduced parathyroid functional mass after successful kidney transplantation. Kidney Int 1999 Aug;56(2):642–649.

    Article  CAS  PubMed  Google Scholar 

  23. Reinhardt W, Bartelworth H, Jockenhovel F, Schmidt-Gayk H, Witzke O, Wagner K et al. Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transplant 1998 Feb;13(2):436–442.

    Article  CAS  PubMed  Google Scholar 

  24. LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, Li Q et al. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 2005 Jun;45(6):1026–1033.

    Article  CAS  PubMed  Google Scholar 

  25. Querings K, Girndt M, Geisel J, Georg T, Tilgen W, Reichrath J. 25-hydroxyvitamin D deficiency in renal transplant recipients. J Clin Endocrinol Metab 2006 Feb;91(2):526–529.

    Article  CAS  PubMed  Google Scholar 

  26. Bushinsky DA. The contribution of acidosis to renal osteodystrophy. Kidney Int 1995 Jun;47(6):1816–1832.

    Article  CAS  PubMed  Google Scholar 

  27. Krieger NS, Frick KK, Bushinsky DA. Mechanism of acid-induced bone resorption. Curr Opin Nephrol Hypertens 2004 Jul;13(4):423–436.

    Article  CAS  PubMed  Google Scholar 

  28. Welch AA, Bingham SA, Reeve J, Khaw KT. More acidic dietary acid-base load is associated with reduced calcaneal broadband ultrasound attenuation in women but not in men: results from the EPIC-Norfolk cohort study. Am J Clin Nutr 2007 Apr;85(4):1134–1141.

    CAS  PubMed  Google Scholar 

  29. Tuominen JT, Impivaara O, Puukka P, Ronnemaa T. Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 1999 Jul;22(7):1196–1200.

    Article  CAS  PubMed  Google Scholar 

  30. Smets YF, van der Pijl JW, de Fijter JW, Ringers J, Lemkes HH, Hamdy NA. Low bone mass and high incidence of fractures after successful simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant 1998 May;13(5):1250–1255.

    Article  CAS  PubMed  Google Scholar 

  31. Bruce DS, Newell KA, Josephson MA, Woodle ES, Piper JB, Millis JM et al. Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year. Transplantation 1996 Aug 27;62(4):451–456.

    Article  CAS  PubMed  Google Scholar 

  32. Hochberg MC. Racial differences in bone strength. Trans Am Clin Climatol Assoc 2007;118:305–315.

    PubMed  Google Scholar 

  33. Mullin BH, Prince RL, Dick IM, Hart DJ, Spector TD, Dudbridge F et al. Identification of a role for the ARHGEF3 gene in postmenopausal osteoporosis. Am J Hum Genet 2008 Jun;82(6):1262–1269.

    Article  CAS  PubMed  Google Scholar 

  34. Nelson DA, Vande Vord PJ, Wooley PH. Polymorphism in the vitamin D receptor gene and bone mass in African-American and white mothers and children: a preliminary report. Ann Rheum Dis 2000 Aug;59(8):626–630.

    Article  PubMed  Google Scholar 

  35. Ghanekar H, Welch BJ, Moe OW, Sakhaee K. Post-renal transplantation hypophosphatemia: a review and novel insights. Curr Opin Nephrol Hypertens 2006 Mar;15(2):97–104.

    Article  CAS  PubMed  Google Scholar 

  36. Pande S, Ritter CS, Rothstein M, Wiesen K, Vassiliadis J, Kumar R et al. . FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation. Nephron Physiol 2006;104(1):23–32.

    Article  Google Scholar 

  37. Saha HH, Salmela KT, Ahonen PJ, Pietila KO, Morsky PJ, Mustonen JT et al. Sequential changes in vitamin D and calcium metabolism after successful renal transplantation. Scand J Urol Nephrol 1994 Mar;28(1):21–27.

    Article  CAS  PubMed  Google Scholar 

  38. Cayco AV, Wysolmerski J, Simpson C, Mitnick MA, Gundberg C, Kliger A et al. Posttransplant bone disease: evidence for a high bone resorption state. Transplantation 2000 Dec 27;70(12):1722–1728.

    Article  CAS  PubMed  Google Scholar 

  39. de Sevaux RG, Hoitsma AJ, van Hoof HJ, Corstens FJ, Wetzels JF. Abnormal vitamin D metabolism and loss of bone mass after renal transplantation. Nephron Clin Pract 2003 Jan;93(1):C21–C28.

    Article  PubMed  Google Scholar 

  40. Ozdemir FN, Afsar B, Akgul A, Usluogullari C, Akcay A, Haberal M. Persistent hypercalcemia is a significant risk factor for graft dysfunction in renal transplantation recipients. Transplant Proc 2006 Mar;38(2):480–482.

    Article  CAS  PubMed  Google Scholar 

  41. Cunningham J. Pathogenesis and prevention of bone loss in patients who have kidney disease and receive long-term immunosuppression. J Am Soc Nephrol 2007 Jan;18(1):223–234.

    Article  CAS  PubMed  Google Scholar 

  42. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998 Jul 15;102(2):274–282.

    Article  CAS  PubMed  Google Scholar 

  43. Mikuls TR, Julian BA, Bartolucci A, Saag KG. Bone mineral density changes within six months of renal transplantation. Transplantation 2003 Jan 15;75(1):49–54.

    Article  CAS  PubMed  Google Scholar 

  44. Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000 Jun;15(6):993–1000.

    Article  PubMed  Google Scholar 

  45. Meakin CJ, Hopson CN, First MR. Avascular (aseptic) necrosis of bone following renal transplantation. Int J Artif Organs 1985 Jan;8(1):19–20.

    CAS  PubMed  Google Scholar 

  46. Marston SB, Gillingham K, Bailey RF, Cheng EY. Osteonecrosis of the femoral head after solid organ transplantation: a prospective study. J Bone Joint Surg 2002 Dec;84–A(12):2145–2151.

    PubMed  Google Scholar 

  47. Kubo T, Fujioka M, Yamazoe S, Yoshimura N, Oka T, Ushijima Y et al. Relationship between steroid dosage and osteonecrosis of the femoral head after renal transplantation as measured by magnetic resonance imaging. Transplant Proc 1998 Nov;30(7):3039–3040.

    Article  CAS  PubMed  Google Scholar 

  48. Kopecky KK, Braunstein EM, Brandt KD, Filo RS, Leapman SB, Capello WN et al. Apparent avascular necrosis of the hip: appearance and spontaneous resolution of MR findings in renal allograft recipients. Radiology 1991 May;179(2):523–527.

    CAS  PubMed  Google Scholar 

  49. Epstein S, Dissanayake IR, Goodman GR, Bowman AR, Zhou H, Ma Y et al. Effect of the interaction of parathyroid hormone and cyclosporine a on bone mineral metabolism in the rat. Calcif Tissue Int 2001 Apr;68(4):240–247.

    Article  CAS  PubMed  Google Scholar 

  50. El Haggan W, Barthe N, Vendrely B, Chauveau P, Berger F, Aparicio M et al. One year evolution of bone mineral density in kidney transplant recipients receiving tacrolimus versus cyclosporine. Transplant Proc 2002 Aug;34(5):1817–1818.

    Article  CAS  PubMed  Google Scholar 

  51. Stern PH. The calcineurin-NFAT pathway and bone: intriguing new findings. Mol Interv 2006 Aug;6(4):193–196.

    Article  CAS  PubMed  Google Scholar 

  52. Brandenburg VM, Westenfeld R, Ketteler M. The fate of bone after renal transplantation. J Nephrol 2004 Mar–Apr;17(2):190–204.

    PubMed  Google Scholar 

  53. Orcel P, Denne MA, de Vernejoul MC. Cyclosporin-A in vitro decreases bone resorption, osteoclast formation, and the fusion of cells of the monocyte-macrophage lineage. Endocrinology 1991 Mar;128(3):1638–1646.

    Article  CAS  PubMed  Google Scholar 

  54. Josephson MA, Schumm LP, Chiu MY, Marshall C, Thistlethwaite JR, Sprague SM. Calcium and calcitriol prophylaxis attenuates posttransplant bone loss. Transplantation 2004 Oct 27;78(8):1233–1236.

    Article  CAS  PubMed  Google Scholar 

  55. Albano L, Casez JP, Bekri S, Gigante M, Champenois I, Cassuto-Viguier E et al. Effects of tacrolimus vs cyclosporin-A on bone metabolism after kidney transplantation: a cross-sectional study in 28 patients. Nephrol Ther 2005 May;1(2):115–120.

    PubMed  Google Scholar 

  56. Monegal A, Navasa M, Guanabens N, Peris P, Pons F, Martinez de Osaba MJ et al. Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A. Calcif Tissue Int 2001 Feb;68(2):83–86.

    Article  CAS  PubMed  Google Scholar 

  57. Goffin E, Devogelaer JP, Lalaoui A, Depresseux G, De Naeyer P, Squifflet JP et al. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation. Transpl Int Mar 2002;15(2–3):73–80.

    Article  CAS  PubMed  Google Scholar 

  58. Gal-Moscovici A, Popovtzer MM. New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels. Clin Nephrol 2005 Apr;63(4):284–289.

    CAS  PubMed  Google Scholar 

  59. Melton LJ 3rd, Atkinson EJ, O’Fallon WM, Wahner HW, Riggs BL. Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res 1993 Oct;8(10):1227–1233.

    Article  PubMed  Google Scholar 

  60. Jamal SA, Hayden JA, Beyene J. Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis. Am J Kidney Dis 2007 May;49(5):674–681.

    Article  PubMed  Google Scholar 

  61. Nickolas TL, Leonard MB, Shane E. Chronic kidney disease and bone fracture: a growing concern. Kidney Int 2008 Sep;74(6):721–731.

    Article  PubMed  Google Scholar 

  62. Cruz EA, Lugon JR, Jorgetti V, Draibe SA, Carvalho AB. Histologic evolution of bone disease 6 months after successful kidney transplantation. Am J Kidney Dis 2004 Oct;44(4):747–756.

    PubMed  Google Scholar 

  63. Palmer SC, Strippoli GF, McGregor DO. Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials. Am J Kidney Dis 2005 Apr;45(4):638–649.

    Article  PubMed  Google Scholar 

  64. Cueto-Manzano AM, Konel S, Freemont AJ, Adams JE, Mawer B, Gokal R et al. Effect of 1,25-dihydroxyvitamin D3 and calcium carbonate on bone loss associated with long-term renal transplantation. Am J Kidney Dis 2000 Feb;35(2):227–236.

    Article  CAS  PubMed  Google Scholar 

  65. El-Agroudy AE, El-Husseini AA, El-Sayed M, Ghoneim MA. Preventing bone loss in renal transplant recipients with vitamin D. J Am Soc Nephrol 2003 Nov;14(11):2975–2979.

    Article  CAS  PubMed  Google Scholar 

  66. Mitterbauer C, Schwarz C, Haas M, Oberbauer R. Effects of bisphosphonates on bone loss in the first year after renal transplantation – a meta-analysis of randomized controlled trials. Nephrol Dial Transplant 2006 Aug;21(8):2275–2281.

    Article  CAS  PubMed  Google Scholar 

  67. Coco M, Glicklich D, Faugere MC, Burris L, Bognar I, Durkin P et al. Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. J Am Soc Nephrol 2003 Oct;14(10):2669–2676.

    Article  CAS  PubMed  Google Scholar 

  68. Szwarc I, Argiles A, Garrigue V, Delmas S, Chong G, Deleuze S et al. Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism. Transplantation 2006 Sep 15 ;82(5):675–680.

    Article  CAS  PubMed  Google Scholar 

  69. Decleire PY, Devogelaer JP, Goffin E. Cinacalcet improves bone mineral density in a renal transplant recipient with persistent hyperparathyroidism. Clin Nephrol 2008 Mar;69(3):231–232.

    PubMed  Google Scholar 

  70. Chou FF, Hsieh KC, Chen YT, Lee CT. Parathyroidectomy followed by kidney transplantation can improve bone mineral density in patients with secondary hyperparathyroidism. Transplantation 2008 Aug 27;86(4):554–557.

    Article  PubMed  Google Scholar 

  71. Collaud S, Staub-Zahner T, Trombetti A, Clerici T, Marangon N, Binet I et al. Increase in bone mineral density after successful parathyroidectomy for tertiary hyperparathyroidism after renal transplantation. World J Surg 2008 Aug;32(8):1795–1801.

    Article  PubMed  Google Scholar 

  72. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY et al. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. New Engl J Med 2001 May 10;344(19):1434–1441.

    Article  CAS  PubMed  Google Scholar 

  73. Saag KG, Shane E, Boonen S, Marin F, Donley DW, Taylor KA et al. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. New Engl J Med 2007 Nov 15;357(20):2028–2039.

    Article  CAS  PubMed  Google Scholar 

  74. Cejka D, Benesch T, Krestan C, Roschger P, Klaushofer K, Pietschmann P et al. Effect of teriparatide on early bone loss after kidney transplantation. Am J Transplant 2008 Sep;8(9):1864–1870.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bradford Lee West MD, FACP .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag US

About this chapter

Cite this chapter

West, B.L., Sprague, S.M., Josephson, M.A. (2010). Bone Disease in Renal Transplantation. In: McKay, D., Steinberg, S. (eds) Kidney Transplantation: A Guide to the Care of Kidney Transplant Recipients. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-1690-7_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1690-7_19

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-1689-1

  • Online ISBN: 978-1-4419-1690-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics